Dongkook Pharmaceutical announced on the 9th that it will halt production of the wound treatment powder Madecassol, the venous circulation disorder improvement medication Sensia tablets, and the hair loss treatment Panthecil capsules for one month (May 23 to June 22). The company received administrative sanctions from the Ministry of Food and Drug Safety for violations of pharmaceutical manufacturer compliance matters. A representative from Dongkook Pharmaceutical noted, "The production halt was due to missing submitted documents," and added, "The products are not problematic."
Q-L Pharma will suspend the production of the bladder and prostate medication Quroid tablets (finasteride) for three months (May 23 to August 22). Q-L Pharma also received administrative sanctions from the Ministry of Food and Drug Safety for violations of pharmaceutical manufacturer compliance matters.
HANALL BIOPHARMA will suspend advertising for the digestive aid Biotop Iseul for two months (May 23 to July 22). HANALL BIOPHARMA received this sanction for not undergoing a review of pharmaceutical advertisements.